Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
申请人:BEECHAM GROUP PLC
公开号:EP0089154A2
公开(公告)日:1983-09-21
compound of formula (I):
wherein;
R' is hydrogen, halogen or trifluoromethyl,
R2 is hydrogen or halogen,
R3 is hydrogen or methyl,
R4 is hydrogen or methyl,
n is 1 or 2
R5 is optionally substituted benzyl or C1-12 straight or branched alkyl optionally substituted by carboxy, C1-6 alkoxycarbonyl, benzyloxycarbonyl, aminocarbonyl, mono- or di-(C1-6)alkylamino-carbonyl, hydroxy, C1-6 alkoxy, benzyloxy, phenoxy, amino, mono- or di-(C1-6)alkylamino, C1-6 alkylthio, benzylthio or pheny-Ithio provided that, when R6 is alkyl substituted by hydroxy, alkoxy, alkylthio, phenylthio, benzylthio, amino, alkylamino or benzyloxy, such substituents are separated from the sulphur atom by at least two carbon atoms, and
Y is methylene or a bond; is useful in treating obesity and hyperglycaemia.
式(I)化合物:
其中
R' 是
氢、卤素或三
氟甲基、
R2 是
氢或卤素
R3 是
氢或
甲基
R4 是
氢或
甲基、
n 是 1 或 2
R5 是任选被取代的
苄基或 C1-12 直链或支链烷基,任选被羧基、C1-6 烷
氧基羰基、苄
氧基羰基、
氨基羰基、单-或二-(C1-6)烷基
氨基羰基、羟基、C1-6 烷
氧基、苄
氧基、
苯氧基、
氨基、单-或二-(C1-6)烷基
氨基取代、C1-6烷
硫基、苄
硫基或
苯硫基,但当 R6 是被羟基、烷
氧基、烷
硫基、
苯硫基、苄
硫基、
氨基、烷基
氨基或苄
氧基取代的烷基时,这些取代基与
硫原子之间至少间隔两个
碳原子,且
Y 是亚
甲基或键;可用于治疗肥胖症和高血糖症。